2023
DOI: 10.1007/s12105-023-01528-y
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic Impact of Tumor Immune Microenvironment and Its Predictive Role in Salivary Gland Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 80 publications
0
6
0
Order By: Relevance
“…Many histological varieties and their distinct features have been proven to greatly influence the interaction between cancer and the immune system ( Table 1 ). Indeed, high or low immunogenicity itself cannot be correlated straight away with a specific prognostic value ( 23 ).…”
Section: Introductionmentioning
confidence: 99%
“…Many histological varieties and their distinct features have been proven to greatly influence the interaction between cancer and the immune system ( Table 1 ). Indeed, high or low immunogenicity itself cannot be correlated straight away with a specific prognostic value ( 23 ).…”
Section: Introductionmentioning
confidence: 99%
“…Although the immune environment is diverse, the majority of studies have focused on PD-L1 expression on tumor cells or tumor infiltrating lymphocytes or PD-1 on tumor-infiltrating lymphocytes. 6,28,30 This has been of particular interest, as it is a therapeutic target for immunotherapies. There is no standard cut-off for positive versus negative expression of PD-L1 by IHC, and several different scoring systems have been used including the Tumor progression score (TPS), which only evaluates staining on viable tumor cells, the Combined positive score (CPS), which includes PD-L1 staining of tumor cells, lymphocytes and macrophages, and the Immune cell score, which evaluates PD-L1 scoring on immune cells.…”
Section: Discussionmentioning
confidence: 99%
“…Most of the literature has described the immune infiltration in salivary gland cancers utilizing immunohistochemistry (IHC). Although the immune environment is diverse, the majority of studies have focused on PD‐L1 expression on tumor cells or tumor infiltrating lymphocytes or PD‐1 on tumor‐infiltrating lymphocytes 6,28,30 . This has been of particular interest, as it is a therapeutic target for immunotherapies.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[52] Currently, the prognostic and predictive aspect of the tumor microclimate is being studied to apply therapies with Programmed cell death ligand 1 inhibitors. [52,53] In the case of benign tumors, inflammation appears to play a crucial role in the development of tumors and can continue to exist throughout the growth process due to its ability to promote cell proliferation. [54] The mean maximum diameter of the tumors supports the heterogeneity of this pathology.…”
Section: Diagnosismentioning
confidence: 99%